[go: up one dir, main page]

PE20200676A1 - Composicion de cannabis - Google Patents

Composicion de cannabis

Info

Publication number
PE20200676A1
PE20200676A1 PE2019000308A PE2019000308A PE20200676A1 PE 20200676 A1 PE20200676 A1 PE 20200676A1 PE 2019000308 A PE2019000308 A PE 2019000308A PE 2019000308 A PE2019000308 A PE 2019000308A PE 20200676 A1 PE20200676 A1 PE 20200676A1
Authority
PE
Peru
Prior art keywords
fraction
weight
composition
cannabis composition
terpene fraction
Prior art date
Application number
PE2019000308A
Other languages
English (en)
Inventor
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61072439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20200676(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zelda Therapeutics Operations Pty Ltd filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of PE20200676A1 publication Critical patent/PE20200676A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se refiere a una composicion farmaceutica topica que comprende un extracto de Cannabis que comprende al menos 75 % en peso de un cannabinoide principal (?9-Tetrahidrocannabinol (THC) o Cannabidiol (CBD); una fraccion de terpeno cuya fraccion comprende limoneno al menos 5,4% en peso de la fraccion de terpeno y un sistema de suministro topico que comprende dos o mas de aceite esencial de bergamota, de cedro, de manzanilla, entre otros. Dicha composicion es util en el tratamiento de un trastorno de la piel.
PE2019000308A 2016-08-03 2017-08-03 Composicion de cannabis PE20200676A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662370303P 2016-08-03 2016-08-03
PCT/AU2017/050815 WO2018023164A1 (en) 2016-08-03 2017-08-03 Cannabis composition

Publications (1)

Publication Number Publication Date
PE20200676A1 true PE20200676A1 (es) 2020-06-11

Family

ID=61072439

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019000308A PE20200676A1 (es) 2016-08-03 2017-08-03 Composicion de cannabis

Country Status (11)

Country Link
US (2) US20190307719A1 (es)
EP (1) EP3493799A4 (es)
JP (1) JP2019523282A (es)
KR (1) KR20190033590A (es)
CN (1) CN109789124A (es)
AU (5) AU2017307644B2 (es)
CA (1) CA3031811A1 (es)
CL (1) CL2019000268A1 (es)
PE (1) PE20200676A1 (es)
SG (1) SG11201900596XA (es)
WO (1) WO2018023164A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190035791A (ko) 2016-08-03 2019-04-03 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
PE20200676A1 (es) 2016-08-03 2020-06-11 Zelda Therapeutics Operations Pty Ltd Composicion de cannabis
WO2018023166A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US11484510B2 (en) * 2017-08-28 2022-11-01 Apirx Pharmaceutical Usa, Llc Method to treat vitiligo
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2019220324A2 (en) * 2018-05-14 2019-11-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
US10736869B2 (en) * 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
IL261774B (en) * 2018-09-13 2020-04-30 Unv Medicine Ltd Compositions for treating dermatological conditions
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
WO2020086291A1 (en) * 2018-10-22 2020-04-30 Jones Lisa Marie Topical compositions incorporating cannabis
WO2020123383A1 (en) * 2018-12-10 2020-06-18 Natural Extraction Systems, LLC Compositions with novel cannabinoid and terpene profiles
WO2020129044A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for skin rejuvenation and skin protection
WO2020129043A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis sativa lines and extracts with anti-cancer properties
WO2020129045A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for treating skin disorders
US20220054380A1 (en) * 2018-12-25 2022-02-24 Epm (Ip), Inc. Cannabidioloic acid esters for cosmetic or edible compositions
WO2020142692A1 (en) * 2019-01-04 2020-07-09 Columbia Care Llc Topical formulations having cannabinoid
US11246310B2 (en) * 2019-02-08 2022-02-15 Global Biolife Inc. Insect repelling composition
US20200345686A1 (en) * 2019-04-30 2020-11-05 Vcp Ip Holdings, Llc, Limited Liability Company Delaware Compositions and methods for treating skin and neuropathic conditions and disorders
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
US20210093539A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical cosmetic
US12343315B2 (en) * 2019-10-21 2025-07-01 Avicanna Inc. Topical cannabinoid compositions for clear skin
US10941131B1 (en) * 2019-10-28 2021-03-09 Pure Tonic Concentrates, LLC Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures
WO2021127559A1 (en) * 2019-12-19 2021-06-24 Natural Extraction Systems, LLC Compositions comprising cannabinoid anions and anti-nucleating agents
CA3165437A1 (en) * 2019-12-19 2021-06-24 Steven Rothstein Extracts enriched with polyphenolic compounds and related methods
WO2021155390A1 (en) * 2020-01-14 2021-08-05 Shaman Naturals, Llc. Antimicrobial compositions
US20210346276A1 (en) * 2020-05-05 2021-11-11 Gm Pharmaceuticals, Inc. Skincare compositions containing cannabidiol
US20210369802A1 (en) * 2020-06-01 2021-12-02 James Chuang Cannabis plant formulations and methods of delivery
US20220054446A1 (en) * 2020-08-18 2022-02-24 Yvette Rose Webb Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils
US20250032567A1 (en) * 2022-02-13 2025-01-30 Reagenics Research Ltd. Plant-based skin preparations and use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
JP2004002237A (ja) * 2002-05-31 2004-01-08 Noriko Yagi 老化防止ハーブ
EP1559423A1 (en) * 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
US9035130B2 (en) * 2007-05-31 2015-05-19 Gw Pharma Limited Reference plant, a method for its production, extracts obtained therefrom and their use
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
PL2444081T3 (pl) * 2010-10-19 2015-09-30 Parenteral A S Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
US20120264818A1 (en) * 2011-04-15 2012-10-18 Jon Newland Topical Compositions with Cannabis Extracts
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
US20130274321A1 (en) * 2012-03-30 2013-10-17 Jon Newland Topical Compositions with Cannabis Extracts
CN104619318A (zh) * 2012-05-03 2015-05-13 回音制药公司 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法
EP2934512B1 (en) * 2012-12-18 2021-11-24 Kotzker Consulting LLC Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
EP2968259B1 (en) * 2013-03-14 2022-09-14 SC Laboratories Inc. Bioactive concentrates and uses thereof
WO2014145490A2 (en) * 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
EP3049076A4 (en) * 2013-09-26 2018-04-18 Ronald D. Sekura Topical treatments incorporating cannabis sp. derived botanical drug product
EP3062606B1 (en) * 2013-10-29 2019-03-20 Biotech Institute, LLC Breeding, production, processing and use of specialty cannabis
JP6377423B2 (ja) * 2014-06-17 2018-08-22 ロート製薬株式会社 外用組成物
EP3160445B1 (en) * 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi related products and methods of use
AU2015308546A1 (en) * 2014-08-25 2017-04-13 Clk Consult V/ Carsten Leonhard Knudsen Device with compositions for delivery to the lungs, the oral mucosa and the brain
CA2859930A1 (en) * 2014-09-22 2016-03-22 Antony Paul Hornby A cannabis topical from heat treated cocount oil
CN113509499A (zh) * 2014-10-21 2021-10-19 联合大麻公司 大麻提取物及其制备和使用方法
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
MX385238B (es) * 2015-11-24 2025-03-14 Constance Therapeutics Inc Composiciones de aceite de cannabis y metodos para preparacion de las mismas.
US20180117161A1 (en) * 2015-12-09 2018-05-03 Poviva Tea, Llc Methods for formulating orally ingestible compositions comprising lipophilic active agents
CA3011185A1 (en) * 2016-01-20 2017-07-27 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
IL301006A (en) * 2016-03-16 2023-04-01 Buzzelet Development And Technologies Ltd Cannobinoid compounds are rich in terpenes
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-emulsifying compositions of cannabinoids
PE20200676A1 (es) 2016-08-03 2020-06-11 Zelda Therapeutics Operations Pty Ltd Composicion de cannabis

Also Published As

Publication number Publication date
AU2019208177B2 (en) 2021-07-01
AU2017307644A1 (en) 2018-07-05
AU2021240296A1 (en) 2021-10-28
KR20190033590A (ko) 2019-03-29
US20190307719A1 (en) 2019-10-10
CN109789124A (zh) 2019-05-21
AU2018100921B4 (en) 2019-02-14
JP2019523282A (ja) 2019-08-22
CA3031811A1 (en) 2018-02-08
SG11201900596XA (en) 2019-02-27
CL2019000268A1 (es) 2019-10-04
WO2018023164A1 (en) 2018-02-08
AU2021240296B2 (en) 2024-03-07
AU2017307644B2 (en) 2019-06-20
EP3493799A1 (en) 2019-06-12
US20220362208A1 (en) 2022-11-17
AU2018100921A4 (en) 2018-08-02
AU2024203468A1 (en) 2024-06-13
EP3493799A4 (en) 2020-04-01
AU2019208177A1 (en) 2019-08-08

Similar Documents

Publication Publication Date Title
PE20200676A1 (es) Composicion de cannabis
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
PE20200726A1 (es) Composicion de cannabis
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
CO2019001043A2 (es) Composición de cannabis
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
MX2021008702A (es) Uso de cannabinoides en el tratamiento de las comorbilidades asociadas a la epilepsia.
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
LT2016046A (lt) Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
MX2024001394A (es) Anticuerpos anti-bcma unicamente de cadena pesada.
CL2017002335A1 (es) Composiciones de cosmetica topica para combatir radicales libres
MX2016010541A (es) Composiciones de canabinoide y usos.
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
CL2017002998A1 (es) Plantas que tienen expresión modificada de thca sintasa
MX2018014978A (es) Composiciones nasales de cannabidiol.
MX2017015083A (es) Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimeto xi-3,3-dimetilindan-1-ona.
GB201111261D0 (en) Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
BR112014023379A8 (pt) Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
MX2021005476A (es) Plantas de cannabis con un perfil de cannabinoides enriquecidas con ¿-9-tetrahidrocannabinol y cannabigerol.
CL2019000198A1 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración.
BR112018012952A2 (pt) composições para higiene pessoal
MX2020004232A (es) Composiciones de cannabinoides y sus metodos de uso.